Clinical Trials Browser

Withdrawn × Sorafenib × Other solid neoplasm × Clear all

NCT02691780 2019-12-30

Study to Evaluate the Safety and Efficacy of Sorafenib, in Subject With Refractory Solid Tumors

Phase NA Withdrawn

Other solid neoplasm

Refractory Solid Tumors

NCT02747537 2019-09-09

Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors With Sorafenib in Combination With Irinotecan

Phase 2 Withdrawn

Other solid neoplasm

Pediatric Solid Tumors